-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711.P1.36 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I

Symposia: Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Silin Sa, Ph.D.1* and Liping Yu, PhD2

1Applied Cells, Santa Clara, CA
2Applied Cells, Inc., Santa Clara, CA

Palani Hamenth Kumar, PhD*, Arun Kumar Arunachalam, MD*, Mohammed Yasar, MSc*, Phaneendra Venkateswara Rao Datari, MD*, Uday Kulkarni, MD, DM, Sushil Selvarajan, MD, DM*, Anu Korula, MD, DM, MRCP*, Aby Abraham, MD, DM*, Biju George, MD, DM and Vikram Mathews, MD, DM

Department of Haematology, Christian Medical College, Vellore, India

Peter Abdelmessieh, MD1, Brittany Ballas, PharmD2*, Michael Styler, MD3, Rashmi Khanal, MD4, Forrest Ridgway, PharmD2*, Michele Sorrentino, PharmD2*, Henry C. Fung, FRCP, MBBChir5 and Asya Varshavsky-Yanovsky4*

1FOX-CHASE Cancer Center, Glen Mills, PA
2FOX-CHASE, Philadelphia, PA
3Bone Marrow Transplant and Cellular Therapies, Fox Chase Cancer Center, Philadelphia, PA
4Fox Chase Cancer Center, Philadelphia, PA
5Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA

Ta-Chuan Yu1*, Tai-Chung Huang, MD2 and Shang-Ju Wu2*

1Department of internal medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan
2Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Byron Figueroa, MSc1*, Martin Ferrando, MD2*, Sebastian Galeano, MD3, Gabriel Borelli, MD2*, Eloisa Riva, MD, MEd4, Alberto Vásquez, MD2*, Ana Carolina Oliver, MD4, Leticia Martinez, MD2*, Victoria Irigoin, MD4*, Rosanna De Giuda, MD2*, Silvia Pierri, MD4*, Claudia Martinez, MD2*, Melanie Isern, MD4*, Cristina Otero2*, Romina Urrutia, MD4*, Victoria Remedi2*, Regis Gai, MD4*, Maria Mori, MD2*, Virginia Marcalain, MD4*, Estefanía López2*, Laura Bello, MD4*, Camila Guidali, MD2*, Lourdes Viano, MD4*, Analia Olivera2*, Martina Perdomo, BSc4*, Virginia Moraes2*, Ana Ines Landoni, MD2* and Pablo Muxi, MD4

1Bone marrow transplant unit, British Hospital, Guatemala, Uruguay
2Bone marrow transplant unit, Hospital Maciel, Montevideo, Uruguay
3Bone marrow transplant unit, British Hospital, Montevideo, Montevideo, Uruguay
4Bone marrow transplant unit, British Hospital, Montevideo, Uruguay

Vladan Vucinic, MD*, David Fandrei, MSc*, Janine Kirchberg*, Enrica Bach, PhD*, Mandy Brueckner*, Kathleen Friedrich*, Carmen Herling, MD*, Madlen Jentzsch, MD*, Georg-Nikolaus Franke, MD*, Simone Heyn, MD*, Uwe Platzbecker, MD and Maximilian Merz, MD

Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany

Stefania Nappo1*, Mario Toriello1*, Giovanna Maisto2*, Francesco Topo1*, Lucia Gallo1*, Giovanni Castellano1*, Roberta Penta de Vera d'aragona1*, Emanuela Rossitti, MD, PhD fellow3*, Alessandra Picardi, MD4*, William G. Wierda5 and Francesco Paolo Tambaro, MD, PhD6

1SSD Cryopreservation and B.a.S.C.O., Oncohematology Department, AORN Santobono-Pausilipon, Naples, Italy
2AORN Santobono-Pausilipon, Naples, Italy
3Stem Cell Transplantation and Cell Therapy Unit, AORN Santobono Pausilipon, Naples, Italy
4Stem Cell Transplant Program AORN Cardarelli, Naples and Biomedicine and Prevencion Department of Tor Vergata University, Rome, Naples / Rome, Italy
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Stem Cell Transplantation and Cell Therapy Unit, AORN Santobono Pausilipon, Napoli, Italy

Beatriz Guijarro-Albaladejo*, Belén Sierro*, Virginia Escamilla Gómez, PhD, MD*, Paola Hernández-Díaz*, María de la Rosa-Garrido*, Inmaculada Carrasco Brocal*, Jose Antonio Bejarano Garcia*, Patricia Alcalde Mellado, MD*, Alfonso Rodriguez Gil, PhD*, Maribel Lara-Chica, PhD*, José Antonio Pérez-Simón, PhD, MD and Estefania Garcia-Guerrero, PhD*

Instituto de Biomedicina de Sevilla (Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla (US), Hospital Universitario Virgen del Rocío (HUVR))., Sevilla, Spain

Xiulian Sun1*, Sheng Zhao2* and Wei Wang2*

1uBriGene Biosciences Inc., Germantown, MD
2uBriGene Biosciences Inc., Nanjing, China

Aimee Marie Merino, MD1*, Ryan Shanley, MS2*, Jenna Langer3*, Faridullah Rashid4*, Emily John3*, Mark B Juckett, M.D., M.H.C.M.5, Jeffrey S Miller, MD6 and Daniel Weisdorf, MD4

1Division of Hematology, Oncology and Transplantation, University of Minnesota, Woodbury, MN
2Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
3UMN, MINNEAPOLIS, MN
4University of Minnesota, Minneapolis, MN
5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
6Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Huimei Guo1*, Jia Liu1*, Hua Xue1*, Songying Zhao1*, Jing Wang1*, Jianmei Xu1*, Jiangbo Zhang1* and Yao Liu2

1Affiliated Hospital of Hebei University, Baoding, China
2Chongqing University Cancer Hospital, Chongqing, China

Melissa Herman, PhD1*, Stefania Gobessi, PhD2*, Laurens Sand, PhD2*, Karolin Wagner, PhD2*, Ryan Yuan, PhD2*, Sterenn Davis, PhD1*, Ian Donaldson, PhD1*, Megan Butler, BSc1*, Natalie Bath, MSc1*, Robert Harris, PhD1*, Nathaniel Golden, BA3*, Alex Tipping, PhD1*, Joseph Sanderson, PhD1*, John Mellors, MD4* and Phillip Debnam, PhD1*

1Adaptimmune, Abingdon, United Kingdom
2Galapagos, Oegstgeest, Netherlands
3Adaptimmune, Cambridge, MA
4Galapagos, Pittsburgh, PA

*signifies non-member of ASH